Introduction
TobraDex ST Ophthalmic is a combination antibiotic and steroid medicine used to treat eye inflammation and prevent bacterial infections․
Overview of TobraDex ST Ophthalmic
TobraDex ST Ophthalmic is a combination medication consisting of tobramycin and dexamethasone․ This ophthalmic suspension is primarily used to address eye inflammation caused by various conditions, including uveitis, eye injuries, and burns․ It serves the dual purpose of treating inflammation and preventing bacterial infections when there is a risk of such infections in or around the eye․ The medication is administered as eye drops in the affected eye(s) at specified intervals based on the severity of the condition․ It is essential to follow the dosage instructions provided by healthcare professionals to achieve optimum results․
TobraDex ST Ophthalmic is an effective treatment option for several inflammatory ocular conditions where the use of a corticosteroid is necessary․ This medication is particularly beneficial in cases of inflammatory conditions of the conjunctiva, cornea, and anterior segment of the eye․ The combination of tobramycin and dexamethasone enables the medication to combat a range of bacterial eye pathogens, including Staphylococci, Streptococci, Pseudomonas aeruginosa, Escherichia coli, and others․ Before initiating treatment with TobraDex ST Ophthalmic, it is crucial to evaluate intraocular pressure and conduct a thorough ophthalmic examination to monitor the response to the medication and adjust the dosage as needed․
Composition and Usage
TobraDex ST Ophthalmic suspension contains 3 mg/mL tobramycin and 0․5 mg/mL dexamethasone․
Ingredients of TobraDex ST Ophthalmic
TobraDex ST Ophthalmic suspension consists of tobramycin (3 mg/mL) and dexamethasone (0․5 mg/mL)․ The combination of these active ingredients provides a potent treatment for various inflammatory ocular conditions susceptible to bacterial infections․
Indications and Dosage Information
TobraDex ST Ophthalmic is indicated for steroid-responsive inflammatory ocular conditions requiring a corticosteroid․ It is particularly effective in addressing inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe․ The medication is used in conditions like chronic anterior uveitis, corneal injuries from burns or foreign bodies, and various other inflammatory ocular issues․ The dual-action formula targets inflammation and combats bacterial infections in the eye, making it suitable for situations where a bacterial infection is present or anticipated․
When using TobraDex ST Ophthalmic, apply one drop into the conjunctival sac every 4 to 6 hours initially٫ with a possible increase to one drop every 2 hours in the first 24 to 48 hours based on the severity of the condition․ It is crucial to gradually adjust the frequency based on clinical improvement and not discontinue treatment prematurely to ensure efficacy․ The elevated IOP and other side effects should be monitored٫ and patients should be reevaluated if no improvement is observed after 2 days of use․
Safety and Considerations
TobraDex ST Ophthalmic should be used cautiously to prevent potential side effects like increased intraocular pressure and delayed healing․
Contraindications and Side Effects
TobraDex ST Ophthalmic is contraindicated in viral diseases of the cornea and conjunctiva, including herpes simplex keratitis․ Possible side effects may include increased intraocular pressure, delayed healing, glaucoma, optic nerve damage, visual acuity defects, and field of vision issues․ It is essential to monitor intraocular pressure during treatment to prevent adverse effects․
Use During Pregnancy and Breastfeeding
TobraDex ST Ophthalmic should be used during pregnancy if the benefits outweigh the potential risks․ Studies in rats showed no fertility impairment at certain doses, but consultation with a healthcare provider is recommended․ It is unclear whether TobraDex ST passes into breast milk, so consult with a healthcare professional before breastfeeding while using this medication․
Administration and Storage
TobraDex ST Ophthalmic should be stored at 2°C to 25°C (36°F to 77°F) and protected from light․ Once opened, it can be used until the expiration date on the bottle․
Proper Administration of TobraDex ST Ophthalmic
One drop of TobraDex ST Ophthalmic should be instilled into the affected eye(s) every 4 to 6 hours initially․ Depending on the severity, the dosage may be increased to one drop every 2 hours in the first 24 to 48 hours․ It is crucial not to discontinue the treatment prematurely to ensure effectiveness while monitoring any adverse effects like increased intraocular pressure carefully․
Storage Guidelines for TobraDex ST Ophthalmic
TobraDex ST Ophthalmic should be stored at temperatures ranging from 2°C to 25°C (36°F to 77°F) and must be safeguarded from light exposure․ Once the bottle is opened, the medication remains usable until the expiry date indicated․